China Medical System Holdings Ltd. (867) fell the most since listing in Hong Kong after the preliminary results of a clinical trial on a liver cancer treatment showed no statistical difference from a placebo in some patient groups.
from Content Keyword RSS http://ift.tt/1f4YzVa
via IFTTT
from Content Keyword RSS http://ift.tt/1f4YzVa
via IFTTT
No comments:
Post a Comment